Ibuprofen-loaded electrospun poly(ethylene-co-vinyl alcohol) nanofibers for wound dressing applications

Chronic wounds are characterized by a prolonged inflammation phase preventing the normal processes of wound healing and natural regeneration of the skin. To tackle this issue, electrospun nanofibers, inherently possessing a high surface-to-volume ratio and high porosity, are promising candidates for the design of anti-inflammatory drug delivery systems. In this study, we evaluated the ability of poly(ethylene-co-vinyl alcohol) nanofibers of various chemical compositions to release ibuprofen for the potential treatment of chronic wounds. First, the electrospinning of poly(ethylene-co-vinyl alcohol) copolymers with different ethylene contents (32, 38 and 44 mol%) was optimized in DMSO. The morphology and surface properties of the membranes were investigated via state-of-the-art techniques and the influence of the ethylene content on the mechanical and thermal properties of each membrane was evaluated. Furthermore, the release kinetics of ibuprofen from the nanofibers in a physiological temperature range revealed that more ibuprofen was released at 37.5 degrees C than at 25 degrees C regardless of the ethylene content. Additionally, at 25 degrees C less drug was released when the ethylene content of the membranes increased. Finally, the scaffolds showed no cytotoxicity to normal human fibroblasts collectively paving the way for the design of electrospun based patches for the treatment of chronic wounds.

Automated summary

The ability of poly(ethylene-co-vinyl alcohol) nanofibers to release ibuprofen for the treatment of chronic wounds was evaluated. The electrospinning of different compositions of poly(ethylene-co-vinyl alcohol) copolymers was optimized, and the release kinetics of ibuprofen from the nanofibers at different temperatures were studied. The scaffolds also showed no cytotoxicity to normal human fibroblasts, indicating their potential for use in chronic wound treatment.